期刊
MOLECULAR ASPECTS OF MEDICINE
卷 45, 期 -, 页码 37-46出版社
ELSEVIER
DOI: 10.1016/j.mam.2015.05.003
关键词
Prostate cancer; Biomarker; RNA; Non-coding; RNA; IncRNA; Gene signatures
资金
- NCI Cancer Center Support Grant [P30CA138292]
- NIH [U01CA113913]
A large number of men are diagnosed with prostate cancer each year, but many will not experience morbidity or mortality as a result of their cancers. Therefore, biomarkers for prostate cancer are necessary to carefully select patients for initial diagnostic biopsy or to facilitate care decisions for men who have already been diagnosed with prostate cancer. RNA-based approaches to biomarker discovery allow the investigation of non-coding RNAs, gene fusion transcripts, splice variants, and multi-gene expression panels in tissue, urine, or blood as opportunities to improve care decisions. This review focuses on RNA biomarkers that are available as commercial assays, and therefore already available for potential clinical use, as well as providing an overview of newer RNA biomarkers that are in earlier stages of clinical development. (C) 2015 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据